Related references
Note: Only part of the references are listed.A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
C. D. Tweed et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
S. E. Dorman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
Tom Decroo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
4-month moxifloxacin containing regimens in the treatment of patients with sputum-positive pulmonary tuberculosis in South India - a randomised clinical trial
Banurekha Velayutham et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2020)
On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomes
Paul Meyvisch et al.
STATISTICS IN MEDICINE (2020)
Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial
P. P. J. Phillips et al.
BMC MEDICINE (2020)
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew J. Nunn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
Christian Lienhardt et al.
PLOS MEDICINE (2019)
Tuberculosis: advances and challenges in development of new diagnostics and biomarkers
Gerhard Walzl et al.
LANCET INFECTIOUS DISEASES (2018)
Quality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review
Laura Jayne Bonnett et al.
TRIALS (2018)
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV A Randomized Clinical Trial
Narendran Gopalan et al.
JAMA INTERNAL MEDICINE (2018)
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad et al.
LANCET (2018)
A stratified approach to tuberculosis treatment
Gavin J. Churchyard
NATURE MEDICINE (2018)
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Marjorie Z. Imperial et al.
NATURE MEDICINE (2018)
Per-Protocol Analyses of Pragmatic Trials
Miguel A. Hernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Challenges in the Design and Interpretation of Noninferiority Trials
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
Patrick P. J. Phillips et al.
BMC MEDICINE (2016)
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
Corinne S. Merle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Stephen H. Gillespie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients
Mohideen S. Jawahar et al.
PLOS ONE (2013)
Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis The Study C Randomized Controlled Trial
Christian Lienhardt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Shortening Treatment in Adults with Noncavitary Tuberculosis and 2-Month Culture Conversion
John L. Johnson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Are patients on treatment for pulmonary TB who stop expectorating sputum genuinely culture negative?
F. M. R. Perrin et al.
THORAX (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial
A Jindani et al.
LANCET (2004)
Share Paper
